Sol Barer

Sol Barer is the Founder and Chairman at Centrexion. He was a former Managing Partner at SJ Barer Consulting.

Dr. Barer is a biotechnology industry veteran, and the founder and former Chairman, President, COO, and CEO of Celgene, a Nasdaq-Listed Company (NASD: CELG).

He brings to InspireMD over 30 years of experience with publicly traded biotechnology companies. In 1980, when Dr. Barer was with Celanese Research Company, he formed the biotechnology group that was subsequently spun out to form Celgene.

Dr. Barer spent 18 years leading Celgene as President, COO and CEO, culminating with his tenure as Celgene’s Executive Chairman and Chairman before retiring in June of 2011. Celgene’s market capitalization at his retirement was approximately $27 billion.

Dr. Barer is a Director of Amicus Therapeutics, Inc., Aegerion Pharmaceuticals, Inc. and ContraFect Corp. and serves as a senior advisor to a number of other biotechnology companies.

Dr. Barer also serves as Chairman of the Board of Trustees of the Biotechnology Council of New Jersey and is on the Board of Trustees of Rutgers University, the Brooklyn College Foundation and the Tourette Syndrome Association.

Dr. Barer was previously the Commissioner of the New Jersey Commission on Science and Technology. Dr. Barer holds a Ph.D. in organic chemistry from Rutgers University and a bachelor’s degree from Brooklyn College.

Sol Barer is the Founder and Chairman at Centrexion Therapeutics. With a background in Biotechnology, Sol Barer has a rich history of leadership and innovation.Sol Barer studied BS Chemistry at CUNY Brooklyn College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.